| DC Field | Value | Language |
|---|
| dc.contributor.author | Soldatov, V. O. | - |
| dc.contributor.author | Shmykova, E. A. | - |
| dc.contributor.author | Pershina, M. A. | - |
| dc.contributor.author | Ksenofontov, A. O. | - |
| dc.contributor.author | Zamitsky, Y. M. | - |
| dc.date.accessioned | 2022-04-27T12:53:08Z | - |
| dc.date.available | 2022-04-27T12:53:08Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.citation | Imidazoline receptors agonists: possible mechanisms of endothelioprotection / V.O. Soldatov [et al.] // Research result: pharmacology and clinical pharmacology. - 2018. - Vol. 4, № 2.- P. 11-19. - DOI: 10.3897/rrpharmacology.4.27221. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46408 | - |
| dc.description.abstract | In this review, the historical, physiological, pathophysiological aspects concerning imidazoline receptor agonists and possible mechanisms for their participation in endothelioprotection were considered. Illuminated the molecular biology of each subtype of imidazoline receptors and their significance in the pharmacological correction of cardiovascular disease | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | endothelial dysfunction | ru |
| dc.subject | imidazoline receptors agonists | ru |
| dc.subject | rats | ru |
| dc.subject | atherosclerosis | ru |
| dc.subject | blood pressure | ru |
| dc.title | Imidazoline receptors agonists: possible mechanisms of endothelioprotection | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 4, № 2
|
